Table 1.
Clinical patient characteristics
| Median age at start of treatment (range), years | 64 (35–83) |
|---|---|
| Number of current chemotherapy lines, n | |
| ≤2 | 19 |
| 1 | 8 |
| 2 | 11 |
| »2 (heavily pretreated) | 16 |
| 3 | 10 |
| 4 | 3 |
| 5 | 1 |
| 6 | 1 |
| 7 | 0 |
| 8 | 1 |
| Number of metastatic sites at start of treatment, n | |
| ≤2 | 26 |
| 1 | 13 |
| 2 | 13 |
| »2 (multiple metastases) | 9 |
| 3 | 5 |
| 4 | 4 |
| Metastatic sites, n | |
| Bone | 20 |
| Liver | 17 |
| Lung | 13 |
| Lymph | 9 |
| Pleura | 6 |
| Other (thoracic wall, cutaneous, cerebral, peritoneum) | 6 |
| Hormone receptor status, n | |
| Positive | 24 |
| Negative | 11 |
| HER2 status, n | |
| Positive | 1 |
| Negative | 34 |